Alteration of bile acid profile in patients with neuromyelitis optica spectrum disorders and multiple sclerosis

This publication has 41 references indexed in Scilit:

• Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management
  Journal of Neurology, 2023
• Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism
  Cell Metabolism, 2021
• Gut microbiome variation is associated to Multiple Sclerosis phenotypic subtypes
  Annals of Clinical and Translational Neurology, 2020
• Neural sphingosine 1‐phosphate accumulation activates microglia and links impaired autophagy and inflammation
  Glia, 2019
• Glucocorticoid treatment alters systemic bile acid homeostasis by regulating the biosynthesis and transport of bile salts
  Digestive and Liver Disease, 2016
• Biomarkers for neuromyelitis optica
  Clinica Chimica Acta, 2015
• Bile acids permeabilize the blood brain barrier after bile duct ligation in rats via Rac1-dependent mechanisms
  Digestive and Liver Disease, 2014
• Cerebrospinal fluid interleukin-6 and glial fibrillary acidic protein levels are increased during initial neuromyelitis optica attacks
  Clinica Chimica Acta, 2013
• TGR5 Activation Inhibits Atherosclerosis by Reducing Macrophage Inflammation and Lipid Loading
  Cell Metabolism, 2011
• Conjugated Bile Acids Activate the Sphingosine–1–Phosphate Receptor 2 in Primary Rodent Hepatocytes
  Hepatology, 2011